Intended for healthcare professionals


Drivers who take insulin must tell Driver and Vehicle Licensing Agency

BMJ 2000; 320 doi: (Published 22 April 2000) Cite this as: BMJ 2000;320:1148
  1. N Essex, member,
  2. P J Watkins, chairman,
  3. J Durston, senior medical adviser
  4. On behalf of the Honorary Medical Advisory Panel on Driving and Diabetes Mellitus
  1. Driver and Vehicle Licensing Agency, Drivers Medical Unit, Swansea SA6 7JL

    EDITOR—The DIGAMI study (diabetes mellitus insulin glucose infusion in acute myocardial infarction) suggested that insulin treatment at the time of myocardial infarction offered some improvement in mortality, particularly in patients not previously treated with insulin.1 As a result of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription